Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-07 Sale |
2022-02-09 7:00 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
10,984 | $80.54 | $884,674 | 462,844 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 6:58 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off |
6,880 | $80.61 | $554,628 | 111,173 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 6:55 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Cooke Julie Chief Human Resources Officer |
2,858 | $80.38 | $229,727 | 17,411 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 6:53 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | BENEVICH ERIC Chief Commercial Officer |
5,099 | $80.57 | $410,821 | 20,338 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 6:51 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
4,290 | $80.53 | $345,486 | 20,204 (Direct) |
View |
| 2022-01-24 Sale |
2022-01-26 5:52 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | SHERWIN STEPHEN A Director |
15,000 | $74.43 | $1,116,378 | 25,055 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-12 5:53 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ROBERTS EIRY Chief Medical Officer |
2,632 | $74.5 | $196,088 | 21,279 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-07 6:04 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off |
28,266 | $85.5 | $2,416,751 | 104,984 (Direct) |
View |
| 2021-12-01 Sale |
2021-12-03 5:02 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
1,645 | $82.59 | $135,852 | 16,349 (Direct) |
View |
| 2021-10-07 Sale |
2021-10-12 6:34 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
5,000 | $105.06 | $525,294 | 208,697 (Direct) |
View |
| 2021-10-07 Sale |
2021-10-12 6:32 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Grigoriadis Dimitri E. Chief Research Officer |
8,000 | $104.81 | $838,510 | 125,673 (Direct) |
View |
| 2021-10-04 Sale |
2021-10-06 4:37 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Cooke Julie Chief Human Resources Officer |
987 | $101.73 | $100,408 | 14,841 (Direct) |
View |
| 2021-08-16 Sale |
2021-08-18 6:18 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | BENEVICH ERIC Chief Commercial Officer |
5,628 | $89.62 | $504,395 | 15,608 (Direct) |
View |
| 2021-07-27 Sale |
2021-07-29 5:32 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer |
16,709 | $93.8 | $1,567,336 | 15,801 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-14 8:25 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
10,000 | $100.27 | $1,002,743 | 213,697 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-31 Option Award |
2022-02-02 8:08 pm |
N/A 2032-01-31 |
NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer |
24,710 | $0 | 24,710 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 8:06 pm |
N/A 2032-01-31 |
NEUROCRINE BIOSCIENCES INC | NBIX | Cooke Julie Chief Human Resources Officer |
54,362 | $0 | 54,362 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 8:04 pm |
N/A 2032-01-31 |
NEUROCRINE BIOSCIENCES INC | NBIX | Grigoriadis Dimitri E. Chief Research Officer |
37,065 | $0 | 37,065 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 8:02 pm |
N/A 2032-01-31 |
NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off |
91,426 | $0 | 91,426 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 8:01 pm |
N/A 2032-01-31 |
NEUROCRINE BIOSCIENCES INC | NBIX | Lippoldt Darin Chief Legal Officer |
74,130 | $0 | 74,130 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 8:00 pm |
N/A 2032-01-31 |
NEUROCRINE BIOSCIENCES INC | NBIX | BENEVICH ERIC Chief Commercial Officer |
71,658 | $0 | 71,658 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 7:58 pm |
N/A 2032-01-31 |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
7,414 | $0 | 7,414 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 7:54 pm |
N/A 2032-01-31 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
76,107 | $0 | 76,107 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 7:52 pm |
N/A 2032-01-31 |
NEUROCRINE BIOSCIENCES INC | NBIX | ROBERTS EIRY Chief Medical Officer |
86,485 | $0 | 86,485 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 7:51 pm |
N/A 2032-01-31 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
160,614 | $0 | 160,614 (Direct) |
View |
| 2022-01-24 Exercise |
2022-01-26 5:52 pm |
N/A 2022-05-23 |
NEUROCRINE BIOSCIENCES INC | NBIX | SHERWIN STEPHEN A Director |
15,000 | $6.66 | 25,055 (Direct) |
View |
| 2022-01-05 Exercise |
2022-01-07 6:04 pm |
N/A 2022-01-12 |
NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off |
28,266 | $8.66 | 104,984 (Direct) |
View |
| 2021-12-14 Gift |
2021-12-16 6:44 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | SHERWIN STEPHEN A Director |
2,000 | $0 | 25,055 (Direct) |
View |
| 2021-12-10 Gift |
2021-12-14 7:43 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | Lippoldt Darin Chief Legal Officer |
120 | $0 | 34,448 (Direct) |
View |
| 2021-11-29 Option Award |
2021-12-01 8:02 pm |
N/A 2031-11-29 |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
137,871 | $0 | 137,871 (Direct) |
View |
| 2021-10-07 Exercise |
2021-10-12 6:32 pm |
N/A 2027-02-06 |
NEUROCRINE BIOSCIENCES INC | NBIX | Grigoriadis Dimitri E. Chief Research Officer |
5,000 | $43.24 | 125,673 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:12 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | Sharp Shalini Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:11 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | RASTETTER WILLIAM H Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:10 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | SHERWIN STEPHEN A Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:09 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | POPS RICHARD F Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:08 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | Norwalk Leslie V Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:07 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | MORROW GEORGE J Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:06 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | Mercier Johanna Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:03 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-16 4:04 pm |
N/A 2031-04-15 |
NEUROCRINE BIOSCIENCES INC | NBIX | Mercier Johanna Director |
17,180 | $0 | 17,180 (Direct) |
View |
| 2021-02-08 Option Award(A) |
2021-03-29 06:24 am |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | ROBERTS EIRY Chief Medical Officer |
49,049 | $0 | 49,049 (Direct) |
View |